| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
AzathioprinePemphigus vulgarisPTCH| 1 | 1995 | Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics. | 
| + | - | nl | J R Soc Med 88(3):155P-160P (1995) |
| 2 | 1992 | Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: a review. |
| + | - | nl | J R Soc Med 85(12):752-6 (1992) |
| 3 | 2008 | Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris. |
| + | - | nl | Arch Dermatol 144(9):1143-7 (2008) Firooz A |
| 4 | 2004 | Pharmacogenomics and IBD: TPMT and thiopurines. |
| + | - | nl | Inflamm Bowel Dis 10 Suppl 1():S35-7 (2004) Sandborn WJ |
| 5 | 2007 | Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease. |
| + | - | nl | Aliment Pharmacol Ther 26(5):643-52 (2007) Van Dieren JM |
| 6 | 2002 | Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. |
| + | - | nl | Aliment Pharmacol Ther 16(7):1225-32 (2002) |
| 7 | 2008 | PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. |
| + | - | nl | Br J Cancer 99(8):1276-84 (2008) Harwood CA |
| 8 | 2007 | Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase. |
| + | - | nl | Eur Respir J 30(5):1014-7 (2007) Perri D |
| 9 | 2004 | Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. |
| + | - | nl | Rheumatology (Oxford) 43(1):13-8 (2004) Clunie GP |
